AU2003235095A1 - Piperidine derivatives - Google Patents
Piperidine derivativesInfo
- Publication number
- AU2003235095A1 AU2003235095A1 AU2003235095A AU2003235095A AU2003235095A1 AU 2003235095 A1 AU2003235095 A1 AU 2003235095A1 AU 2003235095 A AU2003235095 A AU 2003235095A AU 2003235095 A AU2003235095 A AU 2003235095A AU 2003235095 A1 AU2003235095 A1 AU 2003235095A1
- Authority
- AU
- Australia
- Prior art keywords
- piperidine derivatives
- piperidine
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/54—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K15/00—Anti-oxidant compositions; Compositions inhibiting chemical change
- C09K15/04—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds
- C09K15/30—Anti-oxidant compositions; Compositions inhibiting chemical change containing organic compounds containing heterocyclic ring with at least one nitrogen atom as ring member
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-153988 | 2002-05-28 | ||
JP2002153988 | 2002-05-28 | ||
PCT/JP2003/005169 WO2003099788A1 (en) | 2002-05-28 | 2003-04-23 | Piperidine derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003235095A1 true AU2003235095A1 (en) | 2003-12-12 |
Family
ID=29561337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003235095A Abandoned AU2003235095A1 (en) | 2002-05-28 | 2003-04-23 | Piperidine derivatives |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPWO2003099788A1 (en) |
AU (1) | AU2003235095A1 (en) |
WO (1) | WO2003099788A1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005030721A1 (en) * | 2003-09-30 | 2005-04-07 | Nippon Chemiphar Co., Ltd. | Piperidine derivative |
WO2012135669A1 (en) * | 2011-04-01 | 2012-10-04 | Weingarten M David | Nitrogen ring containing compounds for treatment of inflammatory disorders |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0482071B1 (en) * | 1989-07-14 | 1998-01-07 | Biodor U.S. Holding Corporation | New antiviral agents |
FR2655649B1 (en) * | 1989-12-12 | 1994-07-08 | Adir | NOVEL PIPERIDINE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM. |
TW198008B (en) * | 1991-04-08 | 1993-01-11 | Green Cross Corp |
-
2003
- 2003-04-23 WO PCT/JP2003/005169 patent/WO2003099788A1/en active Application Filing
- 2003-04-23 AU AU2003235095A patent/AU2003235095A1/en not_active Abandoned
- 2003-04-23 JP JP2004507445A patent/JPWO2003099788A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2003099788A1 (en) | 2003-12-04 |
JPWO2003099788A1 (en) | 2005-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2003211362A1 (en) | N-hydroxycarboxamide derivative | |
PL375220A1 (en) | Piperidine derivatives | |
AU2003239909A1 (en) | Enhanced-service provision | |
EP1682493B8 (en) | Amidoacetonitrile derivatives | |
HK1072251A1 (en) | Piperidine derivative | |
AU2003255492A1 (en) | Heterocyclic derivatives | |
AU2003224111A1 (en) | Substituted pyrazolo-pyrimidine-4-ones | |
WO2003072535A8 (en) | Substituted hydroxyethylamines | |
EP1606277B8 (en) | Imidazol-4-yl-ethynyl-pyridine derivatives | |
AU2003238043A1 (en) | Substituted imidazotriazines | |
AU2003245984A1 (en) | Hetero-cyclicaly substituted imidazotriazines | |
AU2003301968A1 (en) | 4-aminomethyl-1-aryl-cyclohexylamine derivatives | |
AU2003264753A1 (en) | 1-sulphonyl piperidine derivatives | |
AU2003235913A1 (en) | Cyanopyrrolidine derivatives | |
AU2003231388A1 (en) | Novel piperidine derivative | |
AU2003294900A1 (en) | Substituted 5-aminomethyl-1h-pyrrole-2-carboxamides | |
AU2003303648A1 (en) | Novel 5-hydroxyindole-3-carboxylate derivatives | |
AU2003278369A1 (en) | 3-cyano-quinoline derivatives | |
AU2003296564A1 (en) | 4-hydroxymethyl-1-aryl-cyclohexylamine derivatives | |
EP1706373B8 (en) | Amidoacetonitrile derivatives | |
AU2003222659A1 (en) | 23-o-substituted 5-o-mycaminosyltylonide derivatives | |
AU2003234131A1 (en) | 5-o-mycaminosyltylonide derivatives | |
AU2003212366A1 (en) | Substituted 4-aminocyclohexanols | |
AU2003902882A0 (en) | Piperidyl derivatives | |
AU2003257637A1 (en) | Proline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |